Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành hóa học dành cho các bạn yêu hóa học tham khảo đề tài: Troponin utilization in patients presenting with atrial fibrillation/flutter to the emergency department: retrospective chart review | Meshkat et al. International Journal of Emergency Medicine 2011 4 25 http content 4 1 25 o International Journal of Emergency Medicine a SpringerOpen Journal ORIGINAL RESEARCH Open Access Troponin utilization in patients presenting with atrial fibrillation flutter to the emergency department retrospective chart review l I - -7- V--. Il lz r l klz f 1C I l Al I I ỉ V 2 D i h rzi h I r I Z z-l z l I 3 I_I m I z-l ZZ -7- I_I m 1 z l 14 D S-. I . ĩ z l I_I r r t ki5 All A z l It mn z l6 Nazanin Iviesnkat Emily Austin ndnim Ivioineddin Hamidreza Hatamabadi Benzad Hassani All Abdalvand and Amanda Marcuzzi7 Abstract Background There are few recommendations about the use of cardiac markers in the investigation and management of atrial fibrillation flutter. Currently it is unknown how many patients with atrial fibrillation flutter undergo troponin testing and how positive troponin results are managed in the emergency department. We sought to look at the emergency department troponin utilization patterns. Methods We performed a retrospective chart review of patients with atrial fibrillation flutter presenting to the emergency department at three centers. Outcome measures included the rates of troponins ordered by emergency doctors number of positive troponins and those with positive troponins treated as acute coronary syndrome ACS by consulting services. Results Four hundred fifty-one charts were reviewed. A total of 388 86 of the patients had troponins ordered had positive results and were treated for ACS. Conclusions Troponin tests are ordered in a high percentage of patients with atrial fibrillation flutter presenting to emergency departments. Five percent of our total patient cohort was diagnosed as having acute coronary syndrome by consulting services. Introduction The prevalence of atrial fibrillation is estimated at among adults younger than 55 years rising with age to 9 in those older than 80 1 2 with clear implications in resource .
